Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 2011 AL 2025

PUBMED

Objective quantification of neuromotor symptoms in Parkinson's disease: implementation of a portable, computerized measurement tool.

Papapetropoulos S, Katzen HL, Scanlon BK, Guevara A, Singer C, Levin BE.

Parkinsons Dis. 2010 Jun 30;2010:760196. doi: 10.4061/2010/760196.

0

0

0

PUBMED

Parkinson disease: deep brain stimulation versus best medical therapy for PD.

Brodsky MA, Nutt JG.

Nat Rev Neurol. 2010 Oct;6(10):530-2. doi: 10.1038/nrneurol.2010.128. No abstract available.

0

0

0

PUBMED

Safety and efficacy of flecainide in the treatment of symptomatic children with Wolff-Parkinson-White syndrome.

Núñez F, Ruiz-Granell R, Martínez-Costa C, Morell S, Brines J.

Pediatr Cardiol. 2010 Nov;31(8):1162-5. doi: 10.1007/s00246-010-9772-z.

0

0

0

PUBMED

The role of pramipexole in a severe Parkinson's disease model in mice.

Elhak SG, Ghanem AA, Abdelghaffar H, Eldakroury S, Eltantawy D, Eldosouky S, Salama M.

Ther Adv Neurol Disord. 2010 Nov;3(6):333-7. doi: 10.1177/1756285610389655.

0

0

0

PUBMED

Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.

Xu K, Xu YH, Chen JF, Schwarzschild MA.

Neuroscience. 2010 May 5;167(2):475-81. doi: 10.1016/j.neuroscience.2010.02.020.

0

0

0

PUBMED

Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.

Chen JJ.

Am J Manag Care. 2010 Mar;16 Suppl Implications:S87-93. Review.

0

0

0

PUBMED

Excitability of the lower-limb area of the motor cortex in Parkinson's disease.

Vacherot F, Attarian S, Eusebio A, Azulay JP.

Neurophysiol Clin. 2010 Aug;40(4):201-8. doi: 10.1016/j.neucli.2010.04.002.

0

0

0

PUBMED

Social anxiety in patients with Parkinson's disease.

Bolluk B, Ozel-Kizil ET, Akbostanci MC, Atbasoglu EC.

J Neuropsychiatry Clin Neurosci. 2010 Fall;22(4):390-4. doi: 10.1176/appi.neuropsych.22.4.390.

0

0

0

PUBMED

The relationship between anosmia, constipation, and orthostasis and Parkinson's disease duration: results of a pilot study.

Ramjit AL, Sedig L, Leibner J, Wu SS, Dai Y, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH.

Int J Neurosci. 2010 Jan;120(1):67-70. doi: 10.3109/00207450903337721.

0

0

0

PUBMED

Parkinson's disease: functional changes in frontal and parietal cortex using 18 F- fluoro-deoxy glucose positron emission tomography/computed tomography.

Hou Z, Hong S, Sun B, Lin X, Liu Q, Yao S, Liu S.

Neurol India. 2010 Jan-Feb;58(1):53-7. doi: 10.4103/0028-3886.60397.

0

0

0

PUBMED

The bare essentials: Parkinson's disease.

Lees A.

Pract Neurol. 2010 Aug;10(4):240-6. doi: 10.1136/jnnp.2010.217836. Review. No abstract available.

0

0

0

PUBMED

Study of an integrated non-motor symptoms questionnaire for Parkinson's disease.

Yu B, Xiao ZY, Li JZ, Yuan J, Liu YM.

Chin Med J (Engl). 2010 Jun;123(11):1436-40.

0

0

0

PUBMED

Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease.

Wang ES, Sun Y, Guo JG, Gao X, Hu JW, Zhou L, Hu J, Jiang CC.

Acta Neurol Scand. 2010 Nov;122(5):350-9. doi: 10.1111/j.1600-0404.2009.01318.x.

0

0

0

PUBMED

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.

Bronzova J, Sampaio C, Hauser RA, Lang AE, Rascol O, Theeuwes A, van de Witte SV, van Scharrenburg G; Bruegel Study Group..

Mov Disord. 2010 Apr 30;25(6):738-46. doi: 10.1002/mds.22948.

0

0

0

PUBMED

Discovering neuroprotection in Parkinson's disease, or getting to haphazard.

Kieburtz K.

Mt Sinai J Med. 2010 Nov-Dec;77(6):700-6. doi: 10.1002/msj.20219.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy